A Study to Compare the Efficacy and Safety of Fluticasone Furoate Nasal Sprays (FFNS) 55 microgram (mcg) and 110 mcg in Chinese Pediatric Subjects with Allergic Rhinitis (AR)

Trial Identifier: 201492
Sponsor: GlaxoSmithKline
Start Date: September 2015
Primary Completion Date: October 2017

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
China Beijing, China, 100034
China Beijing, China
China Changsha, China
China Chongqing, China, 400014
China Fuzhou, China, 350025
China Hangzhou, China, 310052
China Shanghai, China, 200127
China Shanghai, China, 200092
China Shanghai, China, 200040
China, Fujian Xiamen, Fujian, China, 361003
China, Guangdong Shenzhen, Guangdong, China, 518038
China, Hunan Changsha, Hunan, China, 410005
China, Hunan Changsha, Hunan, China, 410011
China, Jiangsu Nanjing, Jiangsu, China, 210029
China, Shanxi Taiyuan, Shanxi, China, 030016
China, Zhejiang Wenzhou, Zhejiang, China, 323027